Publication: Sustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation
dc.contributor.author | Narawat Nuamnaichati | en_US |
dc.contributor.author | Vilasinee Hirunpanich Sato | en_US |
dc.contributor.author | Primchanien Moongkarndi | en_US |
dc.contributor.author | Warisara Parichatikanond | en_US |
dc.contributor.author | Supachoke Mangmool | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2019-08-23T10:38:19Z | |
dc.date.available | 2019-08-23T10:38:19Z | |
dc.date.issued | 2018-01-15 | en_US |
dc.description.abstract | © 2017 Elsevier Inc. Paracrine factors, including growth factors and cytokines, released from cardiac myocytes following β-adrenergic receptor (β-AR) stimulation regulate cardiac fibroblasts. Activated cardiac fibroblasts have the ability to increase collagen synthesis, cell proliferation and myofibroblast differentiation, leading to cardiac fibrosis. However, it is unknown which β-AR subtypes and signaling pathways mediate the upregulation of paracrine factors in cardiac myocytes. In this study, we demonstrated that sustained stimulation of β-ARs significantly induced synthesis and secretion of growth factors, including connective tissue growth factor (CTGF) and vascular endothelial growth factor (VEGF), via the cAMP-dependent and protein kinase A (PKA)-dependent pathways. In addition, isoproterenol (ISO)-mediated synthesis and secretion of CTGF and VEGF through the β1-AR and β2-AR subtypes. Paracrine factors released by cardiac myocytes following sustained β-AR stimulation are necessary for the induction of cell proliferation and synthesis of collagen I, collagen III and α-smooth muscle actin (α-SMA) in cardiac fibroblasts, confirming that β-AR overstimulation of cardiac myocytes induces cardiac fibrosis by releasing several paracrine factors. These effects can be antagonized by β-blockers, including atenolol, metoprolol, and propranolol. Thus, the use of β-blockers may have beneficial effects on the treatment of myocardial fibrosis in patients with heart failure. | en_US |
dc.identifier.citation | Life Sciences. Vol.193, (2018), 257-269 | en_US |
dc.identifier.doi | 10.1016/j.lfs.2017.10.034 | en_US |
dc.identifier.issn | 18790631 | en_US |
dc.identifier.issn | 00243205 | en_US |
dc.identifier.other | 2-s2.0-85032955306 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/45267 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85032955306&origin=inward | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Sustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85032955306&origin=inward | en_US |